Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Blend |
| Morningstar category | Foreign Large Blend |
| Launch date | 01 Aug 2019 |
| Price currency | USD |
| Domicile | United States |
| Symbol | FCENX |
| Manager & start date | Chandrakanth Seethamraju 01 Aug 2019 Sundaram Chettiappan 01 Aug 2019 Christopher Floyd 03 Jun 2024 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 915.36m USD As of Oct 31 2024 |
| Share class size | 915.36m USD As of Oct 31 2024 |
| Net expense ratio | 0.00% |
| Front end load | -- |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | 0.00 USD |
| Min. additional investment | -- |
| Initial IRA | -- |
| Additional IRA | -- |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 15.57% | 9.07% | 0.00% | 9.07% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Novo Nordisk A/S NOVO B:CPH | +10.33% | 2.65% | |
| Novartis AG NOVN:SWX | +9.20% | 1.97% | |
| Hitachi Ltd 6501:TYO | +97.67% | 1.64% | |
| ASML Holding NV ASML:AEX | +6.20% | 1.47% | |
| UniCredit SpA UCG:MIL | +65.76% | 1.34% | |
| Per cent of portfolio in top 5 holdings: 9.07% |
Asset type
| Non-US stock | 96.17% |
| Cash | 1.53% |
| US stock | 1.01% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 1.29% |
Top 5 sectors
| Financial Services | 18.14% |
| Industrials | 17.48% |
| Healthcare | 13.21% |
| Consumer Cyclical | 10.59% |
| Consumer Defensive | 8.89% |
| Other | 28.87% |
Top 5 regions
| Eurozone | 31.17% |
| Japan | 23.50% |
| Europe - ex Euro | 18.40% |
| United Kingdom | 13.93% |
| Australasia | 7.08% |
| Other | 3.11% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
